Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies
暂无分享,去创建一个
Janet M. Allen | D. Dunger | R. Hovorka | M. Wilinska | C. Kollman | S. Heller | S. Amiel | J. Allen | D. Elleri | Julie Harris | D. Xing | M. Nodale | K. Kumareswaran | H. Murphy | M. Evans | Stephanie A Amiel | R. Hovorka | D. Dunger | Simon R Heller | Julie Harris | Helen R Murphy | Simon R Heller | Mark L Evans
[1] R. Camerini‐Davalos. PREVENTION OF DIABETES MELLITUS. , 1965, The Medical clinics of North America.
[2] W. F. Taylor,et al. Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability , 1970, Diabetes.
[3] Amir Averbuch,et al. Interacting Multiple Model Methods in Target Tracking: A Survey , 1988 .
[4] Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group. , 1991, The American journal of medicine.
[5] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[6] B P Kovatchev,et al. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. , 1998, Diabetes care.
[7] J. Tuomilehto,et al. Worldwide increase in incidence of Type I diabetes – the analysis of the data on published incidence trends , 1999, Diabetologia.
[8] David Kerr,et al. The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. , 2001, Diabetes care.
[9] John Pickup,et al. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. , 2002, Diabetes care.
[10] R. Hovorka,et al. Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. , 2002, American journal of physiology. Endocrinology and metabolism.
[11] S. Heller,et al. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial , 2002, BMJ : British Medical Journal.
[12] R. Sherwin,et al. Influence of alcohol on cognitive performance during mild hypoglycaemia; implications for Type 1 diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[13] D. Klonoff. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. , 2005, Diabetes care.
[14] Bruce W Bode,et al. Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values. , 2005, Diabetes care.
[15] B. Bequette. A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. , 2005, Diabetes technology & therapeutics.
[16] G. Steil,et al. Closed-loop insulin delivery – what lies between where we are and where we are going? , 2005, Expert opinion on drug delivery.
[17] E Renard,et al. Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system. , 2006, Diabetes & metabolism.
[18] R. Hovorka. Continuous glucose monitoring and closed‐loop systems , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[19] P. Cryer. The Barrier of Hypoglycemia in Diabetes , 2008, Diabetes.
[20] Nigel H Lovell,et al. The use of an Energy Monitor in the management of diabetes: a pilot study. , 2009, Diabetes technology & therapeutics.
[21] C. C. Palerm,et al. Closed-Loop Insulin Delivery Using a Subcutaneous Glucose Sensor and Intraperitoneal Insulin Delivery , 2009, Diabetes Care.
[22] Aaron J. Kowalski,et al. Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: a roadmap to better diabetes outcomes. , 2009, Diabetes technology & therapeutics.
[23] F. Ovalle,et al. Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes , 2009 .
[24] Janet M. Allen,et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial , 2010, The Lancet.
[25] R. Hovorka,et al. Suspended insulin infusion during overnight closed‐loop glucose control in children and adolescents with Type 1 diabetes , 2010, Diabetic Medicine.
[26] George Dailey,et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. , 2010, The New England journal of medicine.
[27] Robert G. Sutherlin,et al. A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes , 2010, Science Translational Medicine.
[28] E. Atlas,et al. MD-Logic Artificial Pancreas System , 2010, Diabetes Care.
[29] W. Kenneth Ward,et al. Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes , 2010, Diabetes Care.
[30] E. Atlas,et al. MD-Logic Artificial Pancreas System: A Pilot Study in Adults with Type 1 Diabetes Mellitus Running Title: Closed-Loop System In Type 1 Diabetes , 2010 .
[31] J. Shaw,et al. Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.
[32] L. Magni,et al. Multinational Study of Subcutaneous Model-Predictive Closed-Loop Control in Type 1 Diabetes Mellitus: Summary of the Results , 2010, Journal of diabetes science and technology.